ArticleInternational journal of medical sciences2025
Green tea containing inulin and catechins ameliorates high-fat diet-induced metabolic dysfunction-associated fatty liver disease in mice.
Article in International journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research Progress and Prospects of Flavonoids in the Treatment of Diseases by Regulating Autophagy: A Narrative Review.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global rise in obesity has contributed to the increasing prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD, formerly known as non-alcoholic fatty liver disease, NAFLD), which is strongly linked to insulin resistance and progression to advanced liver diseases. Dietary factors are thought to influence its development and progression. We aimed to investigate the effect of green tea containing inulin and catechin (IC-GT) on high-fat diet (HFD)-induced MAFLD. Male C57BL/6 mice were assigned to five groups (10 mice/group): control (0 mg IC-GT/kg BW/d), HFD (0 mg IC-GT/kg BW/d), IC-GT-0.5X (1,328 mg IC-GT/kg BW/d), IC-GT-1X (2,645 mg IC-GT/kg BW/d), and IC-GT-2X (5,289 mg IC-GT/kg BW/d). All mice in each group were gavage-fed, received water or test samples for one week, and were then fed an HFD for 18 weeks. Blood and liver tissues were analyzed for lipid profile, enzyme activities, and histopathology. We found that IC-GT supplementation for 18 consecutive weeks significantly reduced aspartate transaminase and alanine transaminase activity as well as total cholesterol, triglyceride, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol concentrations in the blood after HFD intake, and decreased the accumulation of TC and TG in the liver. In addition, histopathological analyses showed a significant reduction in hepatic lipid droplet accumulation. Therefore, our findings suggest that long-term supplementation of IC-GT can significantly ameliorate HFD-induced MAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.